Core Viewpoint - The company has received a medical device registration certificate for its sodium alginate wound dressing from the Jiangsu Provincial Drug Administration, indicating a significant step in product development and regulatory approval [1] Company Summary - The sodium alginate wound dressing is developed to complement the company's core product, Jidesheng Snake Medicine Tablets, aiming to provide a more convenient application method and improved user experience [1]

Core Viewpoint - Jinghua Pharmaceutical (002349.SZ) has received the Medical Device Registration Certificate for its sodium alginate wound dressing from the Jiangsu Provincial Drug Administration, aimed at enhancing the usability and experience of its core product, Jidesheng Snake Medicine Tablets for external use [1] Group 1: Product Development - The sodium alginate wound dressing is developed to assist the external application of Jidesheng Snake Medicine Tablets, providing a more convenient usage method [1] - The product is composed of sodium alginate, glycerin, 1,3-butanediol, and carbomer, with components that have no pharmacological effects and are not absorbed by the human body [1] - It is sterilized through irradiation and designed for single use, creating a suitable moist environment for wound care [1] Group 2: Product Features - The dressing exhibits good biocompatibility and antibacterial properties, making it suitable for the care of superficial wounds and surrounding skin [1] - It facilitates the external application of Jidesheng Snake Medicine Tablets by providing a convenient carrier and appropriate environment for clinical and patient use [1]